1. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis.
    Binghua Zhou et al, 2018, Biomed Pharmacother CrossRef
  2. EphA8 acts as an oncogene and contributes to poor prognosis in gastric cancer via regulation of ADAM10.
    Yingjing Wang et al, 2019, J Cell Physiol CrossRef
  3. Stage‐dependent involvement of ADAM10 and its significance in epileptic seizures
    Xu Zhou et al, 2019, J Cell Mol Med CrossRef
  4. Role of microRNAs in drug resistance of gastric cancer cells
    Bi-Bo Tan et al, 2019, WCJD CrossRef
  5. Non-coding RNA in drug resistance of gastric cancer
    Ya-Jun Luo et al, 2019, WJGO CrossRef
  6. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression
    Hanqing Hong et al, 2019, Cell Death Dis CrossRef
  7. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis
    Chunmei Zhang et al, 2020, Mol Cell Biochem CrossRef
  8. Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma
    Xinjie Hao et al, 2020, J Int Med Res CrossRef
  9. microRNAs in gastric cancer: biomarkers and therapeutic targets
    Soudeh Ghafouri-Fard et al, 2020, Gene CrossRef
  10. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review)
    Chao Chen et al, 2019, Int J Oncol CrossRef
  11. miR-127 suppresses gastric cancer cell migration and invasion via targeting Wnt7a
    Linlin Wang et al, 2019, Oncol Lett CrossRef
  12. Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
    Carlo Gabriele Tocchetti et al, 2020 CrossRef
  13. P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
    Caterina Costa et al, 2020, Cell Death Dis CrossRef
  14. Long Non-Coding RNAs: Role in Testicular Cancers
    Chiara Bresesti et al, 2021, Front. Oncol. CrossRef
  15. Function of Non-coding RNA in Helicobacter pylori-Infected Gastric Cancer
    Chao Wang et al, 2021, Front. Mol. Biosci. CrossRef
  16. MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy
    Yuanyuan Liang et al, 2021, Biomedicines CrossRef
  17. ZEB1 induces non-small cell lung cancer development by targeting microRNA-320a to increase the expression of RAD51AP1
    Huifeng Wang et al, 2021, Experimental Cell Research CrossRef
  18. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
    Amir Sadra Zangouei et al, 2021, Genes and Environ CrossRef
  19. Cation Lipid-Assisted PEG6-PLGA Polymer Nanoparticles Encapsulated Knocking Down Long ncRNAs Reverse Non-Coding RNA of Xist Through the Support Vector Machine Model to Regulate the Molecular Mechanisms of Gastric Cancer Cell Apoptosis
    Zhengwang Sun et al, 2021, j biomed nanotechnol CrossRef
  20. Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer
    Sera Lim et al, 2020, Oncogenesis CrossRef
  21. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-nolysine kinases 1 (WNK1) axis
    Xiaolei Wang et al, 2021, Bioengineered CrossRef
  22. LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis
    Jing Tan et al, 2021, Cellular Signalling CrossRef
  23. MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer
    Lihua Jiang et al, 2018, oncol res CrossRef
  24. Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation
    Hao Zhang et al, 2022, J Orthop Surg Res CrossRef
  25. Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia
    Evelien G. E. Hurkmans et al, 2023, Front. Pharmacol. CrossRef
  26. Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets—A Review
    Agnieszka Kalita et al, 2023, CIMB CrossRef
  27. MiR-320a Acts as a Tumor Suppressor in Somatotroph Pituitary Neuroendocrine Tumors by Targeting BCAT1
    Sida Zhao et al, 2023, Neuroendocrinology CrossRef
  28. MicroRNA copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma
    Talita de Carvalho Kimura et al, 2024, Head & Neck CrossRef
  29. MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications
    Fatemeh Hosseinpour-Soleimani et al, 2024, Heliyon CrossRef
  30. A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
    Sooyeon Oh et al, 2025, Sci Rep CrossRef